SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline Diamondback Energy FANG Wall Street Bullish Consensus and Fundamental Upside Signal Favorable Entry Opportunity